Many Contract
Research Organizations (CROs) are consolidating to offer key discovery, early
stage efficiencies, and expert clinical stage trial services in the lab to
speed up drug development.
Over the past
decade or more, the industry has searched for better ways to manage the costs
and risks of drug development for commercial performance and therapeutic
efficacy long after approval.
